ARTICLE | Clinical News
Spectral Diagnostics regulatory update
February 27, 1995 8:00 AM UTC
DIAGF (Toronto) and Princeton BioMeditech Corp. received FDA approval for their Myoglobin panel test. The test differentiates between heart attack symptoms and non-cardiac pain. ...